Company Directory › Robotics & hardware › Smith+Nephew (CORI)

Profile not yet claimed. This profile was compiled by GlobleMatch from public sources on 6 November 2026. It has not been reviewed or endorsed by Smith+Nephew (CORI), and a listing does not imply a partnership with GlobleMatch. If you represent Smith+Nephew (CORI), you can claim this profile to verify and manage it — or request a correction or removal.

Directory Listing · United Kingdom

Smith+Nephew (CORI)Not yet claimed

Smith+Nephew is a UK medical technology group and the leading proponent of handheld surgical robotics. Its CORI Surgical System shrinks the robot into a surgeon-held handpiece: a camera tracks the joint hundreds of times per second while a robotic burr mills bone only within the planned boundaries, so there is no large robotic arm in the operating room.

United KingdomRobotics & hardwarehandheld robotic-assisted orthopaedic surgery (Smith+Nephew plc)

About Smith+Nephew (CORI)

Smith+Nephew is a UK medical technology group and the leading proponent of handheld surgical robotics. Its CORI Surgical System shrinks the robot into a surgeon-held handpiece: a camera tracks the joint hundreds of times per second while a robotic burr mills bone only within the planned boundaries, so there is no large robotic arm in the operating room. CORI works image-free — instead of a pre-operative CT or MRI, it builds a 3D model of the patient’s joint by mapping the anatomy during the operation — and its small, portable cart suits crowded theatres and ambulatory surgery centres. First launched in the US in 2020 as the successor to the NAVIO system, CORI covers total and partial knee replacement and was the first system indicated for robotic-assisted revision knee surgery; CORI Shoulder on the CORI XT configuration adds shoulder arthroplasty, and a CORI Hip application is in development.

Around the handpiece, the Real Intelligence digital-surgery suite adds CORIOGRAPH pre-operative planning and post-operative data tools, working with Smith+Nephew’s own implant families such as JOURNEY II and AETOS. For partners, CORI is the reference handheld alternative to arm-based orthopaedic robots, sold through Smith+Nephew’s global orthopaedics business.

Products & services

  • CORI Surgical System — handheld robotic platform for total and partial knee arthroplasty
  • CORI revision knee application (robotic-assisted revision knee surgery)
  • CORI Shoulder on CORI XT, with the AETOS Shoulder System; CORI Hip in development
  • Real Intelligence digital surgery suite, including CORIOGRAPH pre-operative planning and modelling services
  • CORI Digital Tensioner and related instrumentation for ligament assessment

Questions partners ask

Smith+Nephew is a UK medical technology group and the leading proponent of handheld surgical robotics. Its listed range includes CORI Surgical System, CORI revision knee application, CORI Shoulder on CORI XT, with the AETOS Shoulder System; CORI Hip in development, Real Intelligence digital surgery suite, including CORIOGRAPH pre-operative planning and modelling services.

Smith+Nephew (CORI) is headquartered in Watford, Hertfordshire, United Kingdom; US orthopaedics operations centred in Memphis, Tennessee. Its founding is recorded as: 2020 (CORI Surgical System launched in the US; Smith+Nephew entered surgical robotics in 2016 with the NAVIO platform. Parent Smith+Nephew was founded in 1856).

Parent company Smith+Nephew plc is listed on the London Stock Exchange (LSE: SN.) and on the New York Stock Exchange (NYSE: SNN); the CORI platform is an internal product line, not a separately funded entity.

GlobleMatch Trust Signals

A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.

Public information coverage8 of 9 fields on the standard profile could be filled from public sources.
This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself.
Last verified6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed.

Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.

Sources & verification

  • Company website — smith-nephew.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
  • Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.

Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.

Related companies

More in Robotics & hardware: Stryker (Mako) (orthopaedic robotic-arm assisted surgery (stryker corporation), United States) · Symbotic (end-to-end distribution-centre automation systems, United States) · Zimmer Biomet (ROSA) (orthopaedic and neurosurgical robotic assistance (zimmer biomet holdings), United States)

Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.

Profile facts

HeadquartersWatford, Hertfordshire, United Kingdom (Smith+Nephew corporate headquarters at Croxley Park, Watford, with registered office in London); US orthopaedics operations centred in Memphis, Tennessee
CountryUnited Kingdom
IndustrySurgical robotics — handheld robotic-assisted orthopaedic surgery (Smith+Nephew plc)
Founded2020 (CORI Surgical System launched in the US; Smith+Nephew entered surgical robotics in 2016 with the NAVIO platform. Parent Smith+Nephew was founded in 1856)
Company size— (not publicly disclosed; left blank rather than guessed)
Markets servedGlobal; CORI launched in the US in 2020 and expanded across Europe, Japan, India and other markets
Official websitesmith-nephew.com
Public fundingParent company Smith+Nephew plc is listed on the London Stock Exchange (LSE: SN.) and on the New York Stock Exchange (NYSE: SNN); the CORI platform is an internal product line, not a separately funded entity
Profile statusNot yet claimed
Facts last verified6 November 2026

Represent Smith+Nephew (CORI)?

Claiming this profile is free. Once your claim is verified, you get:

  • Verified badge — on this profile
  • Edit rights — intro, logo, photos, website and contact button
  • Correction channel — for any fact that is wrong
  • Free AI Search Visibility Snapshot — the full report on how AI search engines describe your company
  • GlobleMatch badge pack — for your own website
  • “Recently Claimed” announcement — in the directory
  • Path to a showcase profile — and Founding Claimer highlight for early claimers

Verified with a company-domain email or proof on your official website or social profile. One claim per company; benefits activate after verification.

Not your company, or want it removed? Request a correction or removal.